NCT05849740View on ClinicalTrials.gov

An Exploratory Study of Cluster of Differentiation 38 (CD38) Monoclonal Antibody Combined Corticosteroid in Acquired Hemophilia A

PHASE4RecruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

May 22, 2023

Primary Completion Date

April 30, 2027

Study Completion Date

October 31, 2027

Conditions
Acquired Hemophilia
Interventions
DRUG

Daratumumab and corticosteroid treatment

Daratumumab and corticosteroid treatment

Trial Locations (1)

Unknown

RECRUITING

Chinese Academy of Medical Science and Blood Disease Hospital, Tianjin

All Listed Sponsors
lead

Institute of Hematology & Blood Diseases Hospital, China

OTHER